Common Stock, Shares, Outstanding of BIOXYTRAN, INC from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Bioxytran, Inc quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q3 2025.
  • Bioxytran, Inc Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 89M shares, a 8.21% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BIOXYTRAN, INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 89M +6.75M +8.21% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 89M -88.4M -49.8% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 88.9M -84.2M -48.6% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 86.8M -57.9M -40% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 82.2M -62.1M -43% 30 Sep 2024 10-Q 29 Oct 2024
Q2 2024 177M +45.4M +34.4% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 173M +49.5M +40.1% 31 Mar 2024 10-Q 19 Apr 2024
Q4 2023 145M +21.3M +17.3% 31 Dec 2023 10-K 03 Apr 2025
Q3 2023 144M +21.3M +17.3% 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 132M +132M 30 Jun 2023 10-Q 31 Jul 2023
Q1 2023 124M +12.7M +11.4% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 123M +12.5M +11.3% 31 Dec 2022 10-K/A 13 Jan 2025
Q3 2022 123M +13.1M +12% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 0 -110M -100% 30 Jun 2022 10-Q 31 Jul 2023
Q1 2022 111M +10.2M +10.1% 31 Mar 2022 10-Q 12 May 2023
Q4 2021 111M +13.4M +13.7% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 110M +12.7M +13.1% 30 Sep 2021 10-Q 17 Nov 2021
Q2 2021 110M +12.8M +13.2% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 101M +12.4M +14.1% 31 Mar 2021 10-Q 17 May 2021
Q4 2020 97.5M +11M +12.7% 31 Dec 2020 10-K 11 Apr 2022
Q3 2020 97.2M +11.9M +13.9% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 97M +11.9M +14% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 88.2M +3.13M +3.68% 31 Mar 2020 10-Q 13 May 2020
Q4 2019 86.5M +1.37M +1.61% 31 Dec 2019 10-K 09 Apr 2021
Q3 2019 85.3M +203K +0.24% 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 85.1M -25.3M -22.9% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 85.1M -20.3M -19.3% 31 Mar 2019 10-Q 10 May 2019
Q4 2018 85.1M 0 0% 31 Dec 2018 10-K 18 Mar 2020
Q3 2018 85.1M +50.2M +144% 30 Sep 2018 10-Q 08 Nov 2018
Q2 2018 110M +75.5M +216% 30 Jun 2018 10-Q 31 Jul 2018
Q1 2018 105M +81.6M +343% 31 Mar 2018 10-Q 15 May 2018
Q4 2017 85.1M +56.9M +202% 31 Dec 2017 10-K 13 Mar 2019
Q3 2017 34.9M +3.75M +12% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 34.9M +6.75M +24% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 23.8M -250K -1.04% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 28.2M +15.9M +129% 31 Dec 2016 10-K 02 Apr 2018
Q3 2016 31.2M +18.9M +153% 30 Sep 2016 10-Q 09 Dec 2016
Q2 2016 28.2M +15.9M +129% 30 Jun 2016 10-Q 20 Sep 2016
Q1 2016 24.1M +18.3M +314% 31 Mar 2016 10-Q 20 Sep 2016
Q4 2015 12.3M +6.5M +112% 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 12.3M -279M -95.8% 30 Sep 2015 10-Q 12 Nov 2015
Q2 2015 12.3M -174M -93.4% 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 5.82M -185M -96.9% 31 Mar 2015 10-Q 19 May 2015
Q4 2014 5.82M +1.94M +50% 31 Dec 2014 10-K 20 Sep 2016
Q3 2014 291M +97M +50% 30 Sep 2014 10-Q 13 Nov 2014
Q2 2014 186M -8.03M -4.14% 30 Jun 2014 10-Q 12 Aug 2014
Q1 2014 190M +6.99M +3.81% 31 Mar 2014 10-Q 14 May 2014
Q4 2013 3.88M -157M -97.6% 31 Dec 2013 10-K 10 Apr 2015
Q3 2013 194M +52.8M +37.4% 30 Sep 2013 10-Q 18 Nov 2013
Q2 2013 194M +65.1M +50.6% 30 Jun 2013 10-Q 15 Aug 2013
Q1 2013 183M +64.2M +53.9% 31 Mar 2013 10-Q 15 May 2013
Q4 2012 161M +47.4M +41.6% 31 Dec 2012 10-K 14 Apr 2014
Q3 2012 141M +66.4M +88.8% 30 Sep 2012 10-Q 21 Nov 2012
Q2 2012 129M +62.6M +94.5% 30 Jun 2012 10-Q/A 22 Jan 2013
Q1 2012 119M 31 Mar 2012 10-Q/A 22 Jan 2013
Q4 2011 114M +79.5M +231% 31 Dec 2011 10-K 15 Apr 2013
Q3 2011 74.7M 30 Sep 2011 10-Q/A 31 Dec 2012
Q2 2011 66.2M 30 Jun 2011 10-Q/A 31 Dec 2012
Q4 2010 34.4M 31 Dec 2010 10-K/A 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.